Add BrightSurf on Google Email

Little capsule bot sweeps to success

Researchers at the University of Tokyo have developed a pill-shaped device that can collect samples from the small intestine using a tiny extendable brush. The device is designed to be magnetically controlled, allowing it to move through extracted intestines and sweep useful samples from the intestinal surface. The technology has the p...

SourceUniversity of Tokyo·JournalDevice·TypeExperimental study·DateOct 1, 2026

Exocrine pancreatic insufficiency affects 40% of chronic pancreatitis patients

A systematic review and meta-analysis found that approximately 40% of patients with chronic pancreatitis worldwide develop exocrine pancreatic insufficiency, a condition that can lead to malabsorption, weight loss, and deficiencies in fat-soluble vitamins. Smoking emerged as a significant modifiable risk factor, emphasizing the need fo...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalJournal of Pancreatology·TypeSystematic review·DateSep 28, 2026

China reports real-world surgical outcomes for 6,297 pancreatic cancer patients

A Chinese registry report presents real-world perioperative and survival outcomes for surgically treated pancreatic cancer patients, achieving high overall survival rates and encouraging surgical safety metrics. The study emphasizes the need for national-level benchmarks and standardized clinical protocols for pancreatic surgery in China.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalJournal of Pancreatology·TypeData/statistical analysis·DateSep 25, 2026

Batteries that safely break down in the GI tract could improve ingestible devices

Researchers at MIT have created tiny, bioresorbable batteries that can power ingestible electronic devices, such as RFID tags and capsules that stimulate ghrelin production, for up to three days. The batteries, made from magnesium and molybdenum trioxide, can be fully broken down and absorbed by the body, reducing environmental impact.

SourceMassachusetts Institute of Technology·JournalNature Chemical Engineering·DateSep 21, 2026

As probiotic use surges, microbiome-supportive food consumption stagnates

A study found that probiotic supplement use increased 287% among adults and 786% among young people, while fiber intake remained unchanged, between 2009 and 2023. Probiotic users consumed more high-microbial foods and fiber content than non-users, but these beneficial diet habits may be decreasing due to supplement use.

SourceMichigan Medicine - University of Michigan·JournalClinical Gastroenterology and Hepatology·TypeData/statistical analysis·DateSep 8, 2026

Chinese Medical Journal article: dietary tryptophan prevents sepsis via GPR37 activation

Researchers found that dietary tryptophan supplementation can prevent sepsis by enhancing macrophage bacterial defense through GPR37 activation, which increases phagocytic ability against bacteria. IPyA, a key metabolic product, directly binds to GPR37 on macrophages, activating RAC1/CDC42 and increasing phagocytosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateAug 26, 2026

The effect of plasminogen activator inhibitor-1 transcriptionally upregulated by c-terminal truncated hepatitis B virus X on the development of hepatocellular carcinoma

The study found that Ct-HBx upregulates PAI-1 by opening chromatin and trans-activating its expression, increasing hepatocellular carcinoma risk and prognosis. PAI-1 levels and genetic polymorphisms serve as biomarkers for predicting HCC risk and postoperative prognosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateAug 25, 2026

Advancing toward non-invasive diagnosis of portal hypertension

Non-invasive approaches are expanding options for assessing portal hypertension, with elastography techniques and biochemical markers showing high sensitivity and specificity. AI-powered predictive models combine clinical data to improve diagnosis, but should not replace invasive HVPG, which remains the gold standard.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalPortal Hypertension & Cirrhosis·TypeLiterature review·DateAug 7, 2026

Patients with IBD face elevated risk of psychiatric disorders

Researchers found that patients with inflammatory bowel disease (IBD) are at a significantly higher risk of developing psychiatric disorders, particularly depression and anxiety. The study highlights the importance of early screening and integration of psychological care into routine IBD management to improve quality of life.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateAug 5, 2026

Hidden cell network offers new clues to intestinal healing and disease

Researchers have discovered a hidden network of specialized mesenchymal support cells in the intestine that work together to maintain its inner lining. The study found four distinct populations of cells with unique genetic programs, each occupying specific locations and influencing stem cell activity and immune responses.

SourceThe Hebrew University of Jerusalem·JournalCellular and Molecular Gastroenterology and Hepatology·TypeData/statistical analysis·DateJul 20, 2026

Forus and American Gastroenterological Association announce strategic partnership to improve medication access for GI patients

The partnership aims to streamline prior authorizations, appeals, and financial assistance, addressing delays or denials in accessing prescribed therapies. By combining AGA's clinical leadership with Forus's medication access platform, the collaboration seeks to enhance patient advocacy and access to effective treatments.

Study reveals a distinct subtype of eosinophilic esophagitis

Researchers at Ann & Robert H. Lurie Children's Hospital of Chicago identified a subtype of eosinophilic esophagitis associated with hypermobile joints and autonomic symptoms, including chronic light-headedness. Simple treatments for these symptoms can significantly improve quality of life in affected children.

SourceAnn & Robert H. Lurie Children's Hospital of Chicago·JournalJournal of Allergy and Clinical Immunology·DateJul 6, 2026

New study identifies hypoxic liver injury as a key predictor of mortality in severe ARDS patients

A new study found that hypoxic liver injury is a common complication affecting over one in five patients with severe ARDS, strongly associated with increased mortality. The study suggests that HLI may serve as a valuable prognostic marker and reflection of systemic disease severity in critically ill patients.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeObservational study·DateJul 2, 2026

Researchers discover that a gut bacteria molecule may calm intestinal inflammation by turning down cellular energy

Researchers discovered that enterobactin, produced by certain gut bacteria, can reduce intestinal inflammation by temporarily slowing down cellular energy production. This finding connects to the emerging concept of mitohormesis and has promising implications for treating inflammatory bowel disease.

SourceUniversity of Toledo·JournalGut Microbes·TypeExperimental study·DateJun 11, 2026

The brain, emotions, and the gut. How culture, stress, and social life shape gut health

The latest publication from Wroclaw Medical University reveals that gastrointestinal health is influenced by culture, social relationships, economic status, and individual functioning within society. Chronic stress disrupts communication between the brain and gut, leading to increased symptom severity and reduced quality of life.

SourceWroclaw Medical University·JournalGastroenterology·TypeLiterature review·DateJun 2, 2026

IBS treatment response predicted by gut microbiome in new study

Researchers found distinct gut microbiome characteristics that predicted treatment response to the low FODMAP diet and rifaximin. Patients who responded to these treatments had different microbial signatures, with increases in diversity for those on the low FODMAP diet and resilience against antibiotics for those on rifaximin.

SourceMichigan Medicine - University of Michigan·JournalClinical Gastroenterology and Hepatology·TypeRandomized controlled/clinical trial·DateApr 22, 2026

Natural component from licorice alleviates inflammatory bowel disease in stem cell-based model and in animals

A new study uses a human stem cell-derived model to identify potential therapies for inflammatory bowel disease (IBD), highlighting glycyrrhizin as a promising candidate. Glycyrrhizin significantly prevents intestinal cell death in both stem cell models and mice with IBD, reducing inflammation and cell death.

SourceInternational Society for Stem Cell Research·JournalStem Cell Reports·DateApr 16, 2026

Study finds sex- and race-based disparities in IBS diagnosis rates among US adults

A national survey found significant disparities in IBS diagnosis across sex and racial groups in the US. Men and Black patients are less likely to receive a formal diagnosis compared to women and white patients, despite similar reported healthcare-seeking behavior and symptom severity.

SourceUniversity of California - Los Angeles Health Sciences·JournalClinical Gastroenterology and Hepatology·TypeData/statistical analysis·DateApr 9, 2026

Large clinical RCT trial finds no clear added benefit of catheter ablation for preventing recurrent stroke in patients with atrial fibrillation

A nationwide Japanese trial found that catheter ablation did not reduce the risk of recurrent stroke or major cardiovascular events in patients with atrial fibrillation who had recently experienced a stroke. The study, which enrolled 251 patients and followed them for over three years, suggests that routine addition of catheter ablatio...

SourceKumamoto University·JournalJAMA Neurology·TypeRandomized controlled/clinical trial·DateMar 31, 2026

Early life stress linked to long-lasting digestive issues

A new study suggests that early life stress during pregnancy and early childhood can lead to long-term digestive issues, including gut pain and motility challenges. The research found that early life stress can shape the development of gut-brain communication, contributing to gastrointestinal symptoms in both mice and humans.

SourceNew York University·JournalGastroenterology·DateMar 16, 2026

Mount Sinai, Uniformed Services University join forces to predict and prevent diseases before they start

The ORIGIN study uses advanced molecular tools to identify risk factors and early warning signals in stored blood samples from up to 13,000 service members. By analyzing these data, researchers aim to predict and prevent diseases such as cancer, heart disease, and autoimmune disorders years before symptoms appear.